U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula 2O.Ti
Molecular Weight 79.866
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TITANIUM DIOXIDE

SMILES

[O--].[O--].[Ti+4]

InChI

InChIKey=SOQBVABWOPYFQZ-UHFFFAOYSA-N
InChI=1S/2O.Ti/q2*-2;+4

HIDE SMILES / InChI

Molecular Formula O
Molecular Weight 15.9994
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Ti
Molecular Weight 47.867
Charge 4
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/18503414

Titanium dioxide, also known as titanium(IV) oxide or titania, is the naturally occurring oxide of titanium, chemical formula TiO 2. When used as a pigment, it is called titanium white, Pigment White 6 (PW6), or CI 77891. Generally it is sourced from ilmenite, rutile and anatase. It has a wide range of applications, from paint to sunscreen to food coloring. When used as a food coloring, it has E number E171. World production in 2014 exceeded 9 million metric tons. Titanium dioxide has excellent ultraviolet (UV) resistant qualities and acts as a UV absorbent. In the pharmaceutical industry, titanium dioxide is used in most sunscreens to block UVA and UVB rays, similar to zinc oxide. It is also commonly used as pigment for pharmaceutical products such as gelatin capsules, tablet coatings and syrups. In the cosmetics industry, it is used in toothpaste, lipsticks, creams, ointments and powders. It can be used as an opacifier to make pigments opaque. The FDA has approved the safety of titanium dioxide for use as a colorant in food, drugs and cosmetics, including sunscreens. However, controversy exists as to the safety of titanium dioxide nanoparticles used in the cosmetics industry, for example in sunscreens. Titanium and zinc oxides may be made into the nanoparticle size (0.2-100 nanometers) to reduce the white appearance when applied topically, but retain the UV blocking properties. Recent studies suggest titanium dioxide nanoparticles may be toxic, although further research is needed.

CNS Activity

Curator's Comment: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: ultraviolet induced damage
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
ANTHELIOS 40

Approved Use

Unknown

Launch Date

2008
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Titanium, chromium and cobalt ions modulate the release of bone-associated cytokines by human monocytes/macrophages in vitro.
1996 Dec
Matrix metalloproteinases MMP-2, -9 and tissue inhibitors TIMP-1, -2 expression and secretion by primary human osteoblast cells in response to titanium, zirconia, and alumina ceramics.
2004 Jan 1
Molecular and biomechanical characterization of mineralized tissue by dental pulp cells on titanium.
2005 Jun
Chemokine gene activation in human bone marrow-derived osteoblasts following exposure to particulate wear debris.
2006 Apr
Upregulation of LITAF mRNA expression upon exposure to TiAlV and polyethylene wear particles in THP-1 macrophages.
2007 Apr
Reconsideration of serum Ti(IV) transport: albumin and transferrin trafficking of Ti(IV) and its complexes.
2008 Feb 20
Alumina ceramic particles, in comparison with titanium particles, hardly affect the expression of RANK-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line.
2009 Jun
Influence of metals on cytokines production in connection with successful implantation therapy in dentistry.
2010
Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells.
2010 Jan 12
Titanium ion induces necrosis and sensitivity to lipopolysaccharide in gingival epithelial-like cells.
2010 Oct
The effect of TiO(2) and Ag nanoparticles on reproduction and development of Drosophila melanogaster and CD-1 mice.
2011 Dec 15
Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles.
2011 Jul
Cellular oxidative damage of HEK293T cells induced by combination of CdCl(2) and nano-TiO (2).
2011 Jun
Particle stimulation dephosphorylates glutathione S-transferase π1 of epithelial cells.
2011 Jun 18
Titanium oxide shell coatings decrease the cytotoxicity of ZnO nanoparticles.
2011 Mar 21
Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study.
2011 Sep
Gene expression of zebrafish embryos exposed to titanium dioxide nanoparticles and hydroxylated fullerenes.
2011 Sep
Ovarian dysfunction and gene-expressed characteristics of female mice caused by long-term exposure to titanium dioxide nanoparticles.
2012 Dec
Genetic variation influences immune responses in sensitive rats following exposure to TiO2 nanoparticles.
2014 Dec 4
Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue.
2014 Dec 9
Genotoxicity of silver and titanium dioxide nanoparticles in bone marrow cells of rats in vivo.
2014 Jan 6
Zinc oxide nanoparticles induce migration and adhesion of monocytes to endothelial cells and accelerate foam cell formation.
2014 Jul 1
Normalization of nano-sized TiO2-induced clastogenicity, genotoxicity and mutagenicity by chlorophyllin administration in mice brain, liver, and bone marrow cells.
2014 Nov
Sheet-type titania, but not P25, induced paraptosis accompanying apoptosis in murine alveolar macrophage cells.
2014 Oct 1
Effects of titanium dioxide nanoparticles on lead bioconcentration and toxicity on thyroid endocrine system and neuronal development in zebrafish larvae.
2015 Apr
Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells.
2015 Apr
Release of titanium ions from an implant surface and their effect on cytokine production related to alveolar bone resorption.
2015 Jan 2
Titanium nanoparticle inhalation induces renal fibrosis in mice via an oxidative stress upregulated transforming growth factor-β pathway.
2015 Mar 16
TiO2 nanoparticle-induced neurotoxicity may be involved in dysfunction of glutamate metabolism and its receptor expression in mice.
2016 Jun
Patents

Sample Use Guides

Apply evenly 15 minutes before sun exposure. Reapply as needed or after towel drying, swimming, or perspiring. Children under 6 months of age, ask a doctor.
Route of Administration: Topical
For the in vitro studies, the stratum corneum side of the skin was in contact with either the aqueous or oily commercial dispersion of microfine TiO2 (150 μl/cm^2). The dermis side was placed onto a tissue of cellulose soaked with isotonic phosphate buffered saline (PBS) of pH 7.4. Twenty-four hours after application of the dispersion, the PBS was removed from the skin with a dry paper towel. For the in vivo studies, 2 μl cm−2 of the commercial dispersions and the different formulations were applied onto the ventral side of the forearm of a healthy female volunteer. After 45 min, any dispersion or formulation that had not penetrated the skin was also removed with a paper towel. All penetration tests were performed in triplicate.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:04:03 GMT 2025
Edited
by admin
on Mon Mar 31 18:04:03 GMT 2025
Record UNII
15FIX9V2JP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CI 77891
INCI  
INCI  
Preferred Name English
TITANIUM DIOXIDE
EP   FCC   HSDB   II   INCI   MART.   MI   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD  
INCI  
Official Name English
TITANIUM DIOXIDE [MART.]
Common Name English
C.I. 77891
Common Name English
TITANIUM DIOXIDE [USP MONOGRAPH]
Common Name English
TITANIUM DIOXIDE [EP MONOGRAPH]
Common Name English
TITANIUM DIOXIDE [USP-RS]
Common Name English
CI-(1975)NO.77891
Code English
CI-PIGMENT WHITE 6
Common Name English
TITANIA
Common Name English
TITANIUM OXIDE
Common Name English
INS-171
Code English
SAGENITE
Common Name English
TITANIUM OXIDE [JAN]
Common Name English
TITANIUM DIOXIDE [MI]
Common Name English
INS NO.171
Code English
TITANIUM DIOXIDE [VANDF]
Common Name English
TITANIUM DIOXIDE [ORANGE BOOK]
Common Name English
NSC-15204
Code English
TITANIUM DIOXIDE [FCC]
Common Name English
E 171
Code English
TITANIUM DIOXIDE [II]
Common Name English
NSC-200C
Code English
RUTILE
Common Name English
RUTILE (TIO2)
Common Name English
Titanium dioxide [WHO-DD]
Common Name English
TITANIUM DIOXIDE [HSDB]
Common Name English
TITANIUM DIOXIDE [EP IMPURITY]
Common Name English
CI-77891
Common Name English
TITANIUM DIOXIDE [IARC]
Common Name English
E-171
Code English
Classification Tree Code System Code
CODEX ALIMENTARIUS (GSFA) INS-171
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
CFR 21 CFR 178.3297
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
NCI_THESAURUS C461
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
DSLD 1166 (Number of products:1)
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 38
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
FDA ORPHAN DRUG 199204
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 575
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
JECFA EVALUATION INS-171
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
CFR 21 CFR 352.20
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
CFR 21 CFR 176.170
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
CFR 21 CFR 175.210
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
EU-Orphan Drug EU/3/05/262
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
EPA PESTICIDE CODE NOT YET ASSIGNED
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 576
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
CFR 21 CFR 352.10
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
FDA ORPHAN DRUG 142401
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 577
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
Code System Code Type Description
EVMPD
SUB12611MIG
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
HSDB
869
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
NCI_THESAURUS
C61975
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
MESH
C009495
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
DRUG BANK
DB09536
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
EPA CompTox
DTXSID3021352
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
RS_ITEM_NUM
1667585
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
DRUG CENTRAL
4237
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
CAS
1317-80-2
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
ALTERNATIVE
PUBCHEM
162651
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
CHEBI
46748
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
CAS
13463-67-7
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
RXCUI
38323
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY RxNorm
FDA UNII
15FIX9V2JP
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
WIKIPEDIA
TITANIUM DIOXIDE
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
CHEBI
32234
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
CHEBI
134438
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
ECHA (EC/EINECS)
236-675-5
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
DAILYMED
15FIX9V2JP
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
CAS
1344-29-2
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
ALTERNATIVE
MERCK INDEX
m10898
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY Merck Index
SMS_ID
100000092217
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201136
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
ECHA (EC/EINECS)
215-282-2
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
ALTERNATIVE
NSC
15204
Created by admin on Mon Mar 31 18:04:03 GMT 2025 , Edited by admin on Mon Mar 31 18:04:03 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY